menu_open Columnists
We use cookies to provide some features and experiences in QOSHE

More information  .  Close

Trump DOJ Demands Pause On Another Lawsuit Challenging FDA’s Abortion Pill Permissions

16 0
16.03.2026

1 Trending: ‘Round River’ FBI Op Was A Deep State Conspiracy To Thwart Investigation Into Biden Family Corruption

2 Trending: Hegseth Orders Task Force To Probe DEI Indoctrination At America’s War Colleges

3 Trending: The Crisis In The Strait Of Hormuz Is Worse Because Of Dems’ Disastrous Energy Policy

4 Trending: Trump Needs To Prepare Americans For What Comes Next In Iran

Trump DOJ Demands Pause On Another Lawsuit Challenging FDA’s Abortion Pill Permissions

This is not the first time the Trump administration has moved to pause or dismiss pro-life states’ pleas for legal intervention.

Share Article on Facebook

Share Article on Twitter

Share Article on Truth Social

Share Article via Email

The Trump administration Department of Justice says women and babies whose lives and safety are threatened by popular abortion pills should have to wait until after U.S. Food and Drug Administration’s review of the popular abortion drug mifepristone to get relief.

The DOJ is redirecting its demands for a court-mandated pause on abortion pill lawsuits from the landmark Louisiana v. FDA case to take aim at Texas and Florida for challenging the FDA’s 2000 approval of mifepristone and subsequent expansions. It is under the Biden administration’s 2023 radical mifepristone permissions that anyone in any state can order mail-order pregnancy-ending pills and complete at-home abortions without medical oversight.

In its memorandum filed on Friday, the DOJ demanded the court “stay this litigation pending the outcome of FDA’s review” or........

© The Federalist